BMM
CVS icon

Buffington Mohr McNeal’s CVS Health CVS Stock Holding History

Buffington Mohr McNeal’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,218
Closed -$1.13M – 125
2024
Q1 		$1.13M Hold
14,218
– – 0.21% 63
2023
Q4 		$1.12M Sell
14,218
-1,625
-10% -$116K 0.23% 62
2023
Q3 		$1.11M Sell
15,843
-985
-6% -$69.8K 0.25% 60
2023
Q2 		$1.16M Buy
16,828
+1,520
+10% +$108K 0.25% 61
2023
Q1 		$1.14M Buy
15,308
+950
+7% +$79.7K 0.26% 61
2022
Q4 		$1.34M Buy
14,358
+818
+6% +$78.9K 0.31% 52
2022
Q3 		$1.29M Buy
13,540
+253
+2% +$25K 0.31% 54
2022
Q2 		$1.23M Buy
13,287
+1,762
+15% +$172K 0.27% 63
2022
Q1 		$1.17M Buy
11,525
+1,225
+12% +$129K 0.22% 69
2021
Q4 		$1.06M Buy
10,300
+4,155
+68% +$384K 0.18% 80
2021
Q3 		$521K Buy
6,145
+1,400
+30% +$117K 0.1% 93
2021
Q2 		$396K Hold
4,745
– – 0.08% 104
2021
Q1 		$357K Buy
4,745
+557
+13% +$40.6K 0.08% 104
2020
Q4 		$286K Buy
4,188
+43
+1% +$2.8K 0.07% 106
2020
Q3 		$242K Buy
4,145
+475
+13% +$29.6K 0.06% 109
2020
Q2 		$238K Buy
+3,670
New +$231K 0.07% 108

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Buffington Mohr McNeal's CVS Position: Q2 2024 in Review

Buffington Mohr McNeal sold out of CVS Health (CVS) in Q2 2024, closing a stake of 14,218 shares — an estimated $1.13M sold.

Buffington Mohr McNeal first reported a position in CVS in Q2 2020 and held it in 16 quarters. The position peaked at $1.34M in Q4 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Buffington Mohr McNeal reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Buffington Mohr McNeal sold 14,218 CVS Health shares in Q2 2024, an estimated $1.13M.
  • Buffington Mohr McNeal first reported a position in CVS Health in Q2 2020 and held it in 16 quarters.
  • Buffington Mohr McNeal's CVS Health position peaked at $1.34M in Q4 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Buffington Mohr McNeal's 13F filing for Q2 2024, filed 11 Jul 2024.